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PRELIMINARY AND SHORT REPORT
STUDIES ON URTICARIA PIGMENTOSA: I. RELEASE OF A HEPARINOID
MATERIAL INTO THE CIRCULATION FOLLOWING DIRECT STIMULATION
OF URTICARIA PIGMENTOSA LESIONS*
FBEDERrCK IJRBACIJ, M.D.,f WAIEEN N. BELL, M.D4 AND COLEMAN JACOBSON, M.D.
Urticaria pigmentosa (1) is an uncommon, chronic, inflammatory disease of the skin
characterized histologically by localized deposits of mast cells in the corium and around
the cutaneous appendages. Clinically it manifests itself by the appearance of pigmented
macules and papules which wheal on stroking or other physical irritation.
It has been shown that the metachromatic granules contained in the mast cell cytoplasm
consist of a heparinoid material which prolongs the clotting of blood in vitro (2, 3). However,
most attempts to demonstrate any abnormal heparinoid activity in patients with urticaria
pigmentosa have not met with success (3, 4), even though it has been repeatedly noted that
these skin mast cells discharge their granules and lose much of their metachromasia after
direct physical stimulation (5).
With the rationale that the demonstration of anticoagulant activity might occur only
after maximal stimulation of all or most of the abnormal mast cell deposits, we have
studied the coagulation mechanisms of eight such patients before and after whealing in-
duced by brisk rubbing of the entire body surface with a rough towel. Our results suggest
that the discharge of the mast cell granules is accompanied by an increase in the heparinoid
titer of the subjects blood.
TABLE I
Methods used for study of coagulo gram
Oil Clot Retraction Time Hirschboek (6) 25—45 minutes
Prothrombin Consumption Quick et al. (7) Over 70% in 1 hr.
1-stage Prothrombin Quick 100% of normal
Platelet Count Rees & Ecker 200,000—300,000 cmm.
Heparin Titer Allen et a!. (8) 100—140 gamma protamine
METhOD
Eight patients with typical urticaria pigmentosa served as experimental subjects. Their
ages ranged from one to forty-seven years. (Two adults and six children.) All had the typical
history and physical findings of the disease. Biopsies of representative skin lesions were
performed on all patients and confirmed the clinical impressions. A young adult physician
with marked dermographism but no evidence of urticaria pigmentosa served as control.
The coagulation mechanisms of all patients were studied by means of the tests shown in
Table I. The examinations were performed before and 20, 60, and sometimes 120 minutes
after brisk rubbing of the entire body surface with a bath towel.
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TABLE II
Coagulation tests before and after stimulation in urticaria pigmentosa
Patient
Wheal
Formation Tests
Te
0 mm. 30mm. 120 mm.
1.A.L. 47
2.M.C. 4
3.D.C. 1
4.E.D. 20
5. P. N. 2.5
6.S.G. 7
7.A.S. 5
4+
4+
4+
0-1+
4+
4+
1+
5.5
29
54
87
351
100
5
45
53
100
273
100
3
18
78
389
80
7.5
30
51
85
329
80
8
47
81
1000
257
100
4
29
77
100
276
160
9.5
35
14
40
218
140
5
14
69
100
369
80
7.5
33
27
47
307
60
10
31
78
100
446
120
7.5
29
63
85
302
180
16
69
79
292
160
8
30
79
330
240
10
38
11
39
222
140
8
56
71
100
401
120
8
29
31
54
304
160
8.5
32
77
100
422
120
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TABLE II—Cont.
Patient Age0rs,
Wheal
Formation
1—'—4'
Tests
Time .
0 mm. 30 mm. •120 mm.
8. D. C. 6 3+ Clotting Time (mm)
Oil Clot Retraction Time (mm)
Prothrombin Consumption (%)
1-stage Prothrombin (%)
Platelet Count (thous./cmm)
Heparin Titer (gamma protamine
req'd)
4
29
37.3
276
160
8
30
35.3
330
240
9. J. L. 34 3+ Clotting Time (mm) 7 9
(con- Oil Clot Retraction Time (mm) 30 31
trol) Prothrombin Consumption (%)
1-stage Prothrombin (%)
Platelet Count (thous ./cmm)
Heparin Titer (gamma protamine
req'd)
31
68
445
80
33
61
431
60
RESULTS
All patients showed coagulation tests within normal limits before stimulation except
for two with moderately prolonged 1-stage prothrombin times. Since the prothrombin con-
sumption is expressed as the difference between the prothrombin activity of the plasma and
of the serum, this resulted in a reduction of the prothrombin consumption in these two
cases. One patient (Case 3) showed a slightly elevated heparin titer before stimulation.
Thirty minutes after stimulation only two patients showed a significant prolongation
of their clotting time and the same two showed an increase of their oil clot retraction time.
The latter test includes both the time necessary for clotting and for clot retraction so that
the prolonged clotting time probably contributed in some measure to the increase. There
was no change in the 1-stage prothrombin time, the prothrombin consumption nor in the
platelet count. Six of the eight patients showed a significant rise in titrable heparinoid
activity of their blood. In the three cases in which tests were carried out two hours after
stimulation, all changes had disappeared. No abnormalities were found in the coagulogram
of the control either before or after stimulation. (Table II)
DISCUSSION
As can be seen in Table III, six of the eight patients studied showed an increase in the
titrable serum heparin level. The two negative results were in cases with mildforms of the
disease where no whealing was noted after stimulation.
TABLE III
Heparin Liter before & after stimulation (gamma protamine)
Patient 0 Mm. 30 Miii. 120 Miii.
A.L. 80 180 100
M. C. 100 160 100
D.C. 160 240 —
E.D. 140 140 —
P.N. 80 120 80
S.G. 60 160 —
A.S. 120 120 —
D.C. 160 240 .—
J. L. (control) 80 60 —
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Until recently, the main criterion of the heparinoid activity of the blood was considered
to be the clotting time. Using this criterion, it can be seen that little change takes place in
our patients after brisk stimulation (two of eight cases). However, the clotting time is a
rough test and will not reflect relatively minor changes in heparinoid activity. Although
methods of varying degrees of complexity have been proposed to demonstrate abnormal
heparinoid states, the protamine titration used in our experiments is simple to carry out
and requires a minimum of apparatus.
One of us (W. N. B.) has recently reported that the changes in the coagulation mecha-
nism which accompanied the administration of commercial heparin to rabbits and man
consists of a prolongation of the clotting and oil clot retraction times, reduction in the
prothrombin consumption and elevation of the heparin titer (9). Only two of our patients
showed changes in the clotting and oil clot retraction times and none showed the charac-
teristic changes in the prothrombin consumption. The cause for the failure of these changes
to appear in our cases is unknown, but it must be emphasized that little is known about the
chemical similarities of commerical heparin and the heparinoid material liberated in urti-
caria pigmentosa patients. From the apparent brevity of the heparin titer elevation, it can
be suggested that the effect of physical stimulation on the mast cells acted more like an
"intravenous" injection of commercial heparin than an "intramuscular" injection. This is
to be expected in view of the observed perivascular location of such cells in the sub-cuta-
neous tissue.
SUMMARY
1. An increase in the titrable heparinoid activity of serum has been demonstrated in
six of eight patients with urticaria pigmentosa following brisk generalized rubbing with a
towel. The two failures were patients who had a mild form of the disease and did not show
whealing after stimulation.
2. The increase in heparinoid titer lasted only a short time and was not accompanied
by changes in the oil clot retraction time and prothrombin consumption usually seen follow-
ing injections of commercial heparin. The reason for this is unknown.
3. It is suggested that the abnormal mast cells in urticaria pigmentosa contain a hepari-
noid material which is discharged into the circulation in small quantities after physical
stimulation of the lesions.
The authors are indebted to Drs. A. J. Creskoff and D. M. Pillsbury for valuable advice,
and to Dr. H. B. Beerman for the interpretation of the histologic sections.
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